Paxlovid provides a glimpse into the future against SARS-CoV-2
A recent study reveals that nirmatrelvir is potent and effective against the SARS-CoV-2 Omicron variant.
Source: news-medical.net
Stay updated with breaking news from Vitro Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent study reveals that nirmatrelvir is potent and effective against the SARS-CoV-2 Omicron variant.